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Abstract 
Background:  Antibiotic resistance has become a 
major health problem worldwide in recent years and 
has increased morbidity and mortality as well as the 
cost of health care. Escherichia Coli in particular is a 
notorious microbe which causes multiple infections. 
We conducted this study to determine the 
antimicrobial resistance pattern, to commonly used 
antibiotics, of Escherichia coli obtained from various 
samples at Holy Family Hospital, Rawalpindi. 
Methods: A cross-sectional study was carried out at 
Pathology department, Holy Family Hospital, 
Rawalpindi. Various samples were collected and 
analyzed in the laboratory to determine the presence 
of E. coli by use of microbiological and biochemical 
tests. Antibiotic resistance was determined using the 
disc diffusion method. Previous records were also 
included in the study.  
Results:  Using the results of 363 samples, high 
resistance was found to cefepime (81.2%), ceftriaxone 
(86.6%), cefixime (90.1%), ciprofloxacin (75.6%) and 
Augmentin (90.2%). On the other hand, there was 
less resistance to amikacin (23.1%), imipenem 
(16.6%), meropenem (32.1%) and nitrofurantoin 
(32.4%). The antibiotic resistance was generally more 
in men, and statistically significant differences were 
obtained in the case of cefepime (p=0.003) and 
ceftriaxone (p=0.006). The antibiotic resistance 
pattern also showed some variation with sample 
type. 
Conclusion: E coli has become resistant to many 
commonly prescribed antibiotics like the 
cephalosporins and fluoroquinolones. The resistance 
has been increasing over the years, and clinicians 
must take steps to discourage inappropriate use of 
antibiotics. Imipenem and nitrofurantoin may be 
used as first-line drugs against E coli infections. 
Keywords: Antimicrobial drugs, Escherichia coli, 
antimicrobial resistance  
 
 
Introduction 
Escherichia coli is a lactose-fermenting gram-negative 
bacterium, that is a frequent cause of infection in 
humans.1 It is the most common cause of urinary tract 
infections2, with one study reporting it to be the cause 
of 90% of urinary tract infections.3 It is also associated 
with blood-stream infections, pneumonia and 
meningitis.4-5 It can cause diarrhea, and some 
particularly virulent strains cause bloody diarrhea and 
hemolytic-uremic syndrome.1, 6 
There is increasing antibiotic resistance in E. coli 
worldwide.7 Much of the increase in urinary tract 
infections has been attributed to this increasing 
antibiotic resistance in E. coli and other causative 
organisms.8-9 Antibiotic resistance has become a major 
health problem in recent years and has increased 
morbidity and mortality as well as the costs of health-
care.10 
In Pakistan, the situation is particularly dire because of 
the indiscriminate prescription of antibiotics by 
general practitioners.11 The frequent use of antibiotics 
is perhaps the most important factor which contributes 
to antibiotic resistance in bacteria.12 Lack of awareness, 
poor compliance of patients and use of substandard 
drugs has further complicated matters.  
Therefore, it was important to evaluate the 
antimicrobial sensitivity of E. coli isolates at Holy 
Family Hospital, Rawalpindi. It shed light on the 
effectiveness of various antimicrobial drugs in 
common use and determined which drugs should be 
prescribed less. In addition, the antibiotic sensitivity of 
bacteria is constantly evolving as new drugs are being 
introduced, and conventional ones are being used with 
less frequency.13 Thus it is logical to conduct studies 
about antibiotic sensitivity time and again, in order to 
determine these changing patterns. 
Keeping this background in mind, the objective of our 
research was to determine the antimicrobial sensitivity 
pattern of E. coli isolated from various samples at 
Holy Family Hospital, Rawalpindi. Moreover, we also 
explored the relationship of gender and sample type 
with the resistance to various drugs. Based on our 
study, physicians will be better informed about the 
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appropriate antibiotic choice for infections caused by 
E. coli. 
 
Materials And Methods 
A cross-sectional study was carried out at the 
Department of Pathology, Holy Family Hospital, 
Rawalpindi from May 2017 to July 2017. The study 
population were those patients in the samples of 
whom E. coli was detected at Holy Family Hospital, 
Rawalpindi. 
Using expected proportions of resistance to ampicillin, 
cotrimoxazole, ciprofloxacin and gentamicin as 92%, 
86%, 80% and 62% respectively from a reference 
study11, 95% confidence interval and 5% absolute 
precision, the sample size was calculated to be 363 
according to the WHO sample size calculator.  
Permission was sought from Ethical Committee of 
Institutional Research Forum, Rawalpindi Medical 
University, Rawalpindi. Simple random sampling was 
done, including previous records as well. Various 
biological samples were collected from different wards 
of Holy Family Hospital, Rawalpindi. These were 
transferred to the laboratory and stored at an 
appropriate temperature. Those samples were 
included in the study in which E. coli was detected 
after appropriate biochemical and microbiological 
tests. Repeat samples from the same patient and 
mishandled specimens were excluded from the study. 
The samples were inoculated on appropriate culture 
media at 37 °C for 36 hours. The macroscopic features 
of the colonies, including lactose fermentation, were 
observed to identify them as E. coli. Suspected colonies 
of E. coli were subjected to various biochemical tests 
like TSI, indole, citrate and motility. E. coli gives a 
yellow-yellow result on TSI without production of 
hydrogen sulphide gas, is indole-positive, citrate-
negative and motile.8-9,11 
After identification of E. coli, antibiotic sensitivity 
testing was performed. This was done on Muller 
Hinton agar plates by the standard disc diffusion 
method according to the guidelines of Clinical and 
Laboratory Standards Institute.14 The antibiotics tested 
for were piperacillin-tazobactam (TzP), cefepime, 
ceftriaxone, ceftazidime, cefixime, cefotaxime, 
gentamicin, amikacin, ciprofloxacin, amoxicillin-
clavulanic acid (Augmentin), sulzone, 
chloramphenicol, imipenem, meropenem, 
levofloxacin, nitrofurantoin, and moxifloxacin. The 
resistance to different antibiotics was determined and 
recorded. 
The data was entered and analysed using Statistical 
Package of Social Sciences (SPSS) version 23. The 
categorical variables like gender, sample and 
susceptibility to different antibiotics were expressed as 
both frequencies and percentages. Cross-tabulation 
was done between the resistance to antibiotics and 
gender, and between the resistance and sample type. 
To determine the association between gender and 
antibiotic resistance, Pearson’s chi square test was 
applied at 5% level of significance and p values less 
than 0.05 were considered statistically significant. In 
the case of cefixime and levofloxacin, this test was 
invalid so Fisher’s exact test was used instead to 
determine the p values. 
 
Results 
Samples were comprised of 152 (41.9%) from men and 
190 (52.3%) from women, while the gender was 
missing for 21 (5.8%) samples (Figure I). Samples 
consisted of 123 (33.9%) from urine, 40 (11%) from 
wounds, 21 (5.8%) from Foley’s catheter tips, 20 (5.5%) 
from respiratory system secretions, 97 (26.7%) from 
pus, 11 (3%) from high vaginal swabs (HVS), 20 (5.5%) 
from endotracheal tubes (ETT), and 23 (6.3%) from 
various other sites, but the data was missing for 8 
(2.3%) samples (Figure II). 
When the sensitivity of various antibiotics was 
considered, imipenem was found to be the most 
effective (83.4%). E coli also showed high sensitivity to 
sulzone (72.9%) and amikacin (76.1%). On the other 
hand, there was marked resistance to cefepime 
(81.2%), ceftriaxone (86.6%), cefixime (90.1%), 
ciprofloxacin (75.6%) and Augmentin (90.2%) (Figure  
III). In general, a variable antimicrobial resistance 
pattern of E coli was obtained. 
Most of the antibiotics showed more resistance in 
samples isolated from male patients (Table I). The 
resistance to ciprofloxacin and moxifloxacin was 11.5% 
and 10.3% greater in men compared to women 
respectively, whereas the resistance to gentamicin was 
5.7% more in men. Statistically significant gender 
differences were found in resistance to cefepime (p 
value=0.003) and ceftriaxone (p value=0.006). In both 
these cases, E coli isolated from samples of men 
showed higher resistance.  
However, some antibiotics showed greater resistance 
in females (Table I). Cefixime and chloramphenicol 
showed 10.9% and 12.1% more resistance, 
respectively, in females than in males. Interestingly, 
the resistance to amikacin, sulzone, imipenem and 
nitrofurantoin showed little variation with gender. 
The relationship between sample type and antibiotic 
resistance was also determined (Table 2). The 
frequency of resistance to tazobactam was generally 
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low in different sample types, but was high (72.2%) in 
samples from ETT (endotracheal tubes). Ceftriaxone 
and Augmentin displayed high resistance, including 
100% in respiratory secretions and 75% in HVS (high 
vaginal swabs). The resistance to cefepime was 
maximum (100%) in ETT and respiratory secretions, 
and 33% lesser in urine samples. Ciprofloxacin 
resistance did not vary remarkably with the sample  
 
 
Figure I – Gender of the subjects 
 
 
Figure II – Frequency of different sample types 
  
 
Figure III – Bar chart showing the resistance and 
sensitivity of E. coli to various antibiotics 
Table I – Antimicrobial resistance patterns of E. coli 
related to gender 
Antibiotic Male Female Chi square 
value 
P value 
TZP 33/99 
(33.3%) 
57/146 
(39.0%) 
0.827 0.363 
Cefepime 37/38 
(97.4%) 
57/76 
(75.0%) 
8.762 0.003 
Ceftriaxone 81/85 
(94.2%) 
92/114 
(80.7%) 
7.633 0.006 
Ceftazidime 83/98 
(84.7%) 
97/120 
(80.8%) 
0.599 0.455 
Cefixime 25/29 
(86.2%) 
34/35 
(97.1%) 
* 0.167 
Cefotaxime 39/45 
(86.7%) 
38/46 
(82.6%) 
0.288 0.592 
Gentamicin 19/37 
(51.4%) 
16/35 
(45.7%) 
0.229 0.632 
Amikacin 26/115 
(22.6%) 
36/146 
(24.7%) 
0.149 0.699 
Ciprofloxacin 76/93 
(81.7%) 
85/121 
(70.2%) 
3.714 0.054 
Augmentin 118/131 
(90.1) 
140/156 
(89.7%) 
0.009 0.927 
Sulzone 38/134 
(28.4%) 
40/154 
(26.2%) 
0.177 0.674 
Chloramphenicol 18/51 
(35.3%) 
18/38 
(47.4%) 
1.318 0.251 
Imipenem 20/142 
(14.1%) 
29/174 
(16.7%) 
0.318 0.528 
Meropenem 8/23 
(34.8%) 
10/32 
(31.3%) 
0.076 0.783 
Levofloxacin 9/13 
(69.2%) 
12/19 
(63.2%) 
* 1.000 
Nitrofurantoin 10/31 
(32.3%) 
19/57 
(33.3%) 
0.011 0.918 
Moxifloxacin 46/59 
(78%) 
44/65 
(67.7%) 
1.640 0.120 
* These antibiotics gave an invalid result with the chi 
square test due to low cell counts. Instead, Fisher’s 
exact test was used to calculate the p values. 
 
type. The resistance to sulzone was highest (38.9%) in 
ETT and catheter tips, and lowest (14.3%) in HVS. The 
resistance to chloramphenicol varied from 75% in 
samples obtained from respiratory secretions to 14.3% 
in those obtained from miscellaneous sites. Imipenem 
resistance was low in most samples types, with the 
notable exception of ETT (42.1%). 
 
Table II – Antimicrobial resistance pattern of E. coli in different sample types 
Antibiotic ETT HVS MISC PUS RESP TIP URINE WOUND 
TZP 13/18 
(72.2%) 
2/7 (28.6%) 8/16 
(50.0%) 
17/63 
(27.0%) 
6/14 
(42.9%) 
8/18 
(44.4%) 
25/90 
(27.8%) 
12/25 
(48.0%) 
Cefepime 8/8 
(100.0%) 
0/0 13/14 
(92.9%) 
22/30 
(73.3%) 
10/10 
(100.0%) 
6/7 
(85.7%) 
20/29 
(67.0%) 
12/14 
(85.7%) 
Ceftriaxone 12/12 3/4 15/16 43/54 12/12 16/16 49/61 19/21 
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(100.0%) (75.0%) (93.8%) (79.6%) (100.0%) (100.0%) (80.3%) (90.5%) 
Ceftazidime 13/13 
(100.0%) 
2/3 
(66.7%) 
17/19 
(89.5%) 
53/71 
(74.6%) 
13/14 
(92.9%) 
9/10 
(90.0%) 
44/60 
(73.3%) 
28/31 
(90.3%) 
Cefixime 1/1 
(100.0%) 
5/5 
(100.0%) 
3/3 
(100.0%) 
18/20 
(90.0%) 
4/4 
(100.0%) 
2/2 
(100.0%) 
22/26 
(84.6%) 
9/10 
(90.0%) 
Cefotaxime 5/5 
(100.0%) 
4/4 
(100.0%) 
1/1 
(100.0%) 
21/24 
(87.5%) 
4/4 
(100.0%) 
5/7 
(71.4%) 
33/43 
(76.7%) 
10/11 
(90.9%) 
Gentamicin 1/3 
(33.3%) 
1/3 
(33.3%) 
3/4 
(75.0%) 
15/28 
(53.6%) 
2/4 
(50.0%) 
2/5 
(40.0%) 
8/18 
(44.4%) 
5/12 
(41.7%) 
Amikacin 8/18 
(44.4%) 
1/7 
(14.3%) 
8/19 
(42.1%) 
10/68 
(14.7%) 
8/15 
(53.3%) 
5/19 
(26.3%) 
15/98 
(15.3%) 
10/29 
(34.4%) 
Ciprofloxacin 11/14 
(78.6%) 
4/6 
(66.7%) 
13/15 
(86.7%) 
43/59 
(72.9%) 
11/13 
(84.6%) 
10/13 
(76.9%) 
51/70 
(72.8%) 
22/29 
(75.7%) 
Augmentin 20/20 
(100.0%) 
6/8 
(75.0%) 
17/21 
(81.0%) 
67/78 
(85.9%) 
16/16 
(100.0%) 
17/19 
(89.4%) 
93/104 
(89.4%) 
31/31 
(100.0%) 
Sulzone 7/18 
(38.9%) 
1/7 
(14.3%) 
6/22 
(27.3%) 
20/81 
(24.7%) 
6/18 
(33.3%) 
7/18 
(38.9) 
26/99 
(26.3%) 
8/35 
(22.9%) 
Chloramphenicol 1/4 
(25.0%) 
1/5 
(20.0%) 
1/7 
(14.3%) 
14/32 
(43.8%) 
6/8 
(75.0%) 
4/7 
(57.1%) 
3/16 
(18.8%) 
7/15 
(46.7%) 
Imipenem 8/19 
(42.1%) 
1/11 
(09.1%) 
2/21 
(09.5%) 
10/91 
(11.0%) 
3/19 
(15.7%) 
3/18 
(16.7%) 
22/113 
(19.5%) 
7/38 
(18.4%) 
Meropenem 1/1 
(100.0%) 
0/4 
(00.0%) 
2/2 
(100.0%) 
7/22 
(31.8%) 
1/1 
(100.0%) 
1/6 
(16.7%) 
5/15 
(33.3%) 
1/5 
(20.0%) 
Levofloxacin 2/2 
(100.0%) 
1/1 
(100.0%) 
2/3 
66.7%) 
6/11 
(54.5%) 
3/4 
(75.0%) 
2/3 
(66.7%) 
4/5 
(80.0%) 
2/5 
(40.0%) 
Nitrofurantoin 0/0 1/1 
(100.0%) 
0/0 1/2 
(50.0%) 
0/0 0/0 30/97 
(30.9%) 
0/0 
Moxifloxacin 8/9 
(88.9%) 
3/6 
(50.0%) 
6/6 
(100.0%) 
18/33 
(54.5%) 
5/6 
(83.3%) 
7/9 
(77.8%) 
46/59 
(78.0%) 
4/4 
(100.0%) 
 
Discussion 
Traditionally, the fluoroquinolones have been used for 
infections caused by E. coli. Some older studies report 
the resistance to fluoroquinolones between 20-30%.15, 16 
However, a study conducted in Mexico found that the 
average resistance to fluoroquinolones was more than 
85% in E. coli isolated from various samples.17 
Similarly, studies conducted in Pakistan have found 
high resistance to ciprofloxacin11, 18, indicating that the 
fluoroquinolones are gradually becoming ineffective 
for treating E. coli infections. Our study discovered a 
high resistance not only to ciprofloxacin (75.6%) but 
also to newer fluoroquinolones such as moxifloxacin 
(71.7%) and levofloxacin (64.7%). This is alarming and 
the use of fluoroquinolones for infections caused by E. 
coli must be reduced. It is thought that prolonged 
administration of low doses of fluoroquinolones is a 
major risk factor for resistance.19 
E. coli have become increasingly resistant to other 
traditionally prescribed drugs like ampicillin, 
trimethoprim-sulfamethoxazole, nalidixic acid and 
amoxicillin-clavulanic acid (Augmentin).20 A study 
funded by the National Institute of Biotechnology and 
Genetic Engineering in Faisalabad reported that 
cephradine, ampicillin, streptomycin, trimethoprim-
sulfamethoxazole and tetracycline were largely 
ineffective in cases of UTI caused by E. coli.18 Our 
study was consistent with these results, and found the 
resistance to Augmentin to be 90.2%. The other drugs 
mentioned here were not included in our study, 
because they are not much used at Holy Family 
Hospital, Rawalpindi. 
The cephalosporins have also been used to treat 
infections caused by E. coli. The Mexican study 
reported the resistance to ceftriaxone and ceftazidime 
to be 68.3% and 55.7% respectively.17 Other studies 
also report a moderate degree of resistance to the 
various generations of cephalosporins.11, 20 However, 
our study found a remarkably high resistance to 
cefepime (81.2%), ceftriaxone (86.6%), ceftazidime 
(81.1%), cefixime (90.1%) and cefotaxime (83.3%).  
Most studies have found imipenem to be the antibiotic 
to which the resistance is the least.17, 21 Our study is in 
agreement with this, as the resistance to imipenem was 
16.6%. We also found low resistance to meropenem 
(32.1%) and amikacin (23.9%), which is not contrary to 
the results of previous studies. A study conducted at 
the University of Punjab, Lahore found the resistance 
to amikacin to be 4%.11 
Another drug which is becoming increasingly popular 
to treat E. coli infections is nitrofurantoin. The study at 
University of Punjab, Lahore11 found that only 20% of 
E. coli from urinary tract isolates were resistant to 
nitrofurantoin. Other studies report similarly low 
levels of resistance to nitrofurantoin, and many believe 
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it should be used as an alternative empirical first-line 
drug against E. coli infections.17, 22 Our study was 
consistent with this, and the resistance to 
nitrofurantoin was found to be 32.4%. However, other 
factors must also be considered such as availability, 
cost and adverse effects, which may limit the clinical 
use of nitrofurantoin.  
Gender differences in the resistance to antibiotics are 
reported by various studies. Generally, the resistance 
is discovered to be higher in men.11, 20 Our study also 
found that the resistance to most antibiotics was 
greater in men, but there were some exceptions. A 
study focused solely on female outpatients reported 
lower resistance of E. coli to most antibiotics.23 Most of 
the studies only included E. coli from urine samples. 
However, we included E. coli isolated from many 
different sample types and observed some significant 
variations in the resistance among E. coli collected 
from different sites.  
Conclusion 
E. coli has become resistant to many commonly 
prescribed antibiotics such as cephalosporins and 
fluoroquinolones. These resistance patterns show 
variation with gender and sample type. This increase 
in resistance is a serious issue and there must be a 
concerted effort to reduce the overuse of antibiotics. 
Nitrofurantoin should be prescribed for mild 
infections caused by E. coli, whereas imipenem is more 
suitable for severe infections.  
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